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ABSTRACT The structural integrity of unilamellar vesicles
has been studied in vitro and in vivo by use of gamma-ray
perturbed angular correlation techniques. These studies utilize
li1In3+ weakly bound to the chelator nitrilotriacetic acid as a
probe to monitor the percentage of intact vesicles. When com-
plexes of Illn3+ and nitrilotriacetic acid is encapsulated in
vesicles, lllIn3+ exhibits a fast tumbling rate. Upon alteration
of the membrane, ll1n3+ is released from the liposomes and
becomes bound to macromolecules, consequently exhibiting a
decrease in IlllIn3+ tumbling rate. The in vitro experiments show
that the present technique is capable of determining quantita-
tively the percentage of material released from the vesicues upon
the addition of serum or Triton X-100 to vesicles. The percentage
of vesicles remaining intact in vivo can also be monitored
continuously by the present technique. In mice, the half-life of
dipalmitoyl phosphatidylcholine-cholesterol vesicles after in-
traperitonea injection was estimated to be 10-13 hr. The
present study suggests that the vesicles remain intact in various
tissues for extended periods, thereby allowing a slow release of
the encapsulated material at those sites.
Therapeutic agents encapsulated in liposomes have been suc-
cessfully applied to model systems as diverse as enzyme re-
placement therapy (1-3), heavy metal detoxification (4), and
cancer chemotherapy (5). The increasing interest in the po-
tential of liposomes as carriers for pharmacologically active
agents is demonstrated by several recent reviews (6-9). Answers
to the pervading problem of how to bring functional molecules
into contact with a specific target in a controlled fashion must
be sought through systematic investigations of optimal liposome
size, structure, and membrane composition. Throughout these
investigations, it is essential to know whether the administered
liposomes remain intact. Indium-ill entrapped in liposomes
is ideally suited for this purpose because radioisotope tracer
methods can be used to determine the physical location of '111n,
and the structural integrity of the liposomes can be monitored
in vivo by gamma-ray perturbed angular correlation (PAC)
studies.
The PAC technique as used in these studies monitors changes
in the rotational correlation time of the "'1In ion (10-12). Two
gamma rays are emitted in cascade from the radioactive "'IIn
nucleus and are detected by a coincidence spectrometer. The
coincidence counting rate depends strongly on the angle be-
tween the directions of propagation of the gamma rays. This
angular correlation may be perturbed by interaction of the
radioactive nucleus with its environment. Thus, PAC studies
can provide information concerning changes in the tumbling
rate of I'1'n ions bound to molecules with different rotational
correlation times.
The strategy adopted for determining the intactness of li-
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posomes in vivo is based on the principle that lllIn3+ encap-
sulated in a liposome will exhibit a fast tumbling rate. However,
upon alteration of the structural integrity of the membrane, the
111In3+ will be released from the liposome and should rapidly
become bound to protein, consequently exhibiting a decreased
"'lIn3+ tumbling rate. A chelator, nitrilotriacetic acid (NTA),
was added to the buffers during vesicle formation to minimize
binding of the trivalent cations to phospholipid headgroups.
MATERIALS AND METHODS
L-a-Dipalmitoyl phosphatidylcholine (DPPC) purchased from
GIBCO and cholesterol from Matheson, Coleman and Bell were
used as supplied. The trisodium salt of NTA was obtained from
Aldrich Chemical Co. Fresh rabbit serum was prepared from
the blood of healthy New Zealand White rabbits by allowing
blood collected from an ear vein to clot for 30 min at room
temperature. The clotted blood was centrifuged at 2500 X g,
40, for 20 min; the serum was collected and refrigerated im-
mediately.
Carrier-free "'InCl3 in 0.05 M HCl/0.9% NaCl was obtained
from Medi + Physics, Glendale, CA. The "'IInCl3 was purified
from the saline and other contaminants by chromatography on
Bio-Rad AG 1X-8 (0.7 X 10 cm column) in 0.1 M HCL. The
fractions were collected in Nalgene beakers and taken to dry-
ness under heat lamps. lllIn3+ was complexed to NTA by the
addition of 0.9% NaCI/5 mM sodium phosphate, pH 7.4 (Pi/
NaCI) containing 1 mM NTA to the "'InCl3.
Preparation of Vesicles. Unilamellar vesicles were prepared
from DPPC and DPPC-cholesterol, 2:1, (mol/mol). DPPC
vesicles were prepared by addition of 1.0 ml of a solution con-
taining 1-2 mCi of 11In3+ in 1 mM NTA/Pi/NaCl to 54 ,tmol
of solid DPPC in a small conical tube. For the DPPC-choles-
terol vesicles, the DPPC (27 ,umol) and cholesterol (13.5 ,tmol)
were dissolved in chloroform and dried to a thin film at 420
under a stream of nitrogen; then 0.5 ml of a solution containing
1-2 mCi of "11In3+ in 1 mM NTA/Pi/NaCl was added. The
tubes were shaken briefly by a Vortex mixer and placed into
a Branson sonicator with a titanium microtip. Sonication was
carried out for 15 min at high power in a glycerol bath. The
vesicle suspension was then centrifuged for 15 min at 300 X g,
25°, for 30 min to remove any titanium fragments and highly
aggregated material. The supernatant was clear for DPPC-
cholesterol preparations.,
lllIn3+ not entrapped in the liposomes was removed by
Abbreviations: PAC, gamma-ray perturbed angular correlation; NTA,
nitrilotriacetic acid; DPPC, L-a-dipalmitoyl phosphatidylcholine;
Pi/NaCl, phosphate-buffered saline (0.9% NaCI/5 mM sodium phos-
phate, pH 7.4); (G22(-)), time-integrated perturbation factor.
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FIG. 1. Kinetics of binding of '11In3+ by serum: (G22(-)) as a
function of time. All samples contained 0.15 ml of fresh rabbit serum,
0.05 ml of saline, and the following final concentrations of NTA: o,
0.25 mM; X, 0.050 mM; 0, 0.75 mM; A, 1 mM. Each sample contained
16 ± 1 ,Ci of '11In'+.
passage of the vesicle suspension over two 0.5 X 7 cm Chelex-
100 (Bio-Rad) columns that had previously been equilibrated
with Pi/NaCl. Any remaining external lllIn3+ was removed
by subsequent passage of the vesicles over a 0.8 X 35 cm column
of Sephadex G-50 (Sigma) in Pi/NaCl. The vesicles were col-
lected in the void volume of the column. Radioactivity in col-
umn fractions was monitored with a Nuclear Chicago well-type
gamma-ray spectrometer. Typically, trapping efficiencies of
2-3% were observed. Leakage of lllIn3+ from the vesicles was
subsequently assessed by dialysis of the vesicle preparations at
250 against 1 mM NTA/Pi/NaCl and by chromatography on
Sepharose 4B (Pharmacia) in 0.95% sodium citrate/0.65%
NaCl/0.02% NaN3, pH 5.2. For Sepharose chromatography,
the 0.7 X 70 cm matrix bed included a 60-cm section packed
with 4-mm glass beads.
In Vitro Studies. The binding of "'In3+ to NTA and to
serum proteins was examined by PAC measurements carried
out with a gamma-ray coincidence spectrometer (10). The ki-
netics of binding of lllIn3+ to serum proteins in the presence
of various concentrations of NTA was monitored by measuring
the time-integrated perturbation factor [(G22(o))] of solution
containing 16 + 1 ,uCi of I11n3+. The decrease in the rotational
correlation time of the lllIn3+ accompanying binding of the
lllIn3+ to protein is evidenced by this measurement. The size
of the radioactive source was considered in processing all data,
with measurements being corrected to the level of 0.20 ml in
a 10 X 75 mm glass tube.
The effect of serum on the permeability of vesicles containing
lllIn3+ was investigated by measuring the change in (G22(oo))
with time after the addition of fresh rabbit serum to the vesicle
preparations. After extended periods of incubation at 250 in the
presence of serum, these vesicle preparations were chromato-
graphed on Sepharose 4B to confirm the extent of leakage of
lllIn3+ from the vesicles. When complete release of the en-
trapped NTA-lllIn3+ complex was desired, the vesicles were
disrupted by the addition of chloroform or Triton X-100, or
both.
In Vivo Studies. BALB/c mice from Jackson Laboratories
(Bar Harbor, ME) and C57BL/6 mice bred at California In-
Table 1. Values of (G22(0o)) for "llIn3+ in various environments*
(G22(- ))
Without With
Sample serum serum
NTA-111In3+ complex 0.68 + 0.02 0.18 ± 0.02
DPPC vesicles containing
NTA-11'In3+ 0.50 + 0.02 0.35 + 0.02
DPPC-cholesterol vesicles
containing NTA-111In3+ 0.64 + 0.02 0.60 i 0.02
* All samples in Pi/NaCl prior to the addition of 1 volume of fresh
rabbit serum.
stitute of Technology were used for the in vivo studies. Ad-
ministration of lllln3+ to the mice was by intraperitoneal in-
jection. In vivo PAC studies, using 16 ± 2 ,uCi of "'1In3+ per
mouse, were accomplished by placing the live mouse in the
barrel of a modified plastic syringe centered in the spectrometer
(13). After measurement of the (G22(oo)) of the mouse for pe-
riods of up to 3 hr, the animal was returned to its cage. Addi-
tional measurements were performed at varying intervals
during the 3 days after injection of vesicles containing
lllIn3+.
The tissue distribution of lllIn3+ after intraperitoneal ad-
ministration of lllIn3+-vesicles (0.1 ml of vesicle suspension
containing 3.5 ,4Ci of entrapped NTA-111In3+ per mouse) was
examined. After varying lengths of time, the mice were killed
by cervical dislocation followed immediately by decapitation.
Organs and tissues were washed with 0.9% NaCl, blotted, and
weighed. The distribution of injected radioactivity was deter-
mined by assaying the tissue samples in a well-type gamma-ray
spectrometer.
RESULTS
In Vitro Experiments. Measurement of (G22(co)) of the
sequentially emitted 173- and 247-keV gamma rays of "'1In
provides a convenient method of estimating the rotational
correlation time of the molecule to which the "'IIn ion is bound
(12). Values of (G22(cx)) for llIn3+ in various environments are
shown in Table 1. A rapid tumbling rate (e.g., lllln3+ com-
plexed to the low molecular weight NTA) is characterized by
a relatively high (G22(x)) value. In contrast, 111In3+ bound to
serum proteins exhibits a slow tumbling rate as characterized
by a low (G22(cx)) value. NTA was found to be a suitable che-
lator because at a final concentration of 1 mM it decreased the
extent of binding of 111In3+ to lipid headgroups and still allowed
binding of 111In3+ to serum proteins. The kinetics of binding
of lllln3+ by serum at various final concentrations of NTA is
shown in Fig. 1. At the lower concentrations of NTA (e.g., 0.25
mM), most of the lllIn3+ became bound to serum proteins
within 10 min. This indicates that rupture of vesicles containing
NTA-lllIn3+ should result in a decrease in NTA concentration
sufficient to allow complete binding of "'In3+ by protein
within the time necessary to complete a PAC measurement.
The data in Table 1 also show that lower (G22(a0)) values
were obtained for NTA-lllIn3+ entrapped in vesicles than for
the NTA-111In3+ complex alone. This indicates competitive
binding of 111In3+ to NTA and to the lipid headgroups on the
inner surface of the vesicle. The degree of binding of 11In ions
to the lipid headgroups will depend on the relative binding
constants and on the local concentration of headgroups inside
the vesicle. Thus, the lower value of (G22(c0)) observed for
DPPC vesicle preparations suggests that the average size of
DPPC vesicles is smaller than that of DPPC-cholesterol vesicles.
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FIG. 2. The effect of serum on vesicle integrity as assessed by
Sepharose 4B chromatography. (A) One milliliter of serum/DPPC
vesicles, 1:1 (vol/vol), after incubation of the mixture for 53 hr at 250.
(B) One milliliter of serum/DPPC-cholesterol vesicles, 1:1 (vol/vol)
after incubation for 41 hr at 250. (C) Control incubation 0.8 ml of
DPPC-cholesterol vesicles after 66 hr at 250 in the absence of serum.
The 1.0-ml fractions were collected at a flow rate of 8 ml/hr from the
0.7 X 70 cm column. Fractions 9-10 represent the void volume; frac-
tions 18-22 are the elution volume of serum proteins.
This is supported by the results of the gel filtration studies (Fig.
2). DPPC-cholesterol vesicle preparations were shown by
electron microscopy and analytical ultracentrifugation to be
heterogeneous in size with a mean diameter of 650 A. These
preparations contained less than 10% multilamellar lipo-
somes.
The structural stability of our vesicle preparations was ex-
amined by dialysis of representative preparations of DPPC
vesicles and DPPC-cholesterol vesicles. These measurements
indicated leakages of 3.0% and 2.2%, respectively, in 24 hr at
25°, thus showing that they are of comparable stability in
physiological salt solutions. Addition of rabbit serum, however,
affected the permeability of the two types of vesicles to dif-
ferent extents (Table 1; Fig. 2). The percentage of 111In3+ bound
to serum proteins can be calculated by using the following ex-
pression (10):
(G22(oo)) = x(G22(0z))f + (1 -X)(G22(a'))b [1]
in which x is the mole fraction of lllIn3+ remaining entrapped
within the vesicles, (G22(cx))f is the time integrated pertur-
bation factor of NTA-"'In3+ inside the vesicles, and (G22(o))b
is the factor of II1In3+ bound to protein. By using Eq. 1 and the
data in Table 1, the percentage of IIIIn3+ bound to proteins is
47% for the DPPC vesicles and 9% for the DPPC-cholesterol
vesicles after incubation with fresh rabbit serum. These values
are in good agreement with the results of gel filtration (Fig. 2
A and B) which show 47% and 12% binding of HIn3M, re-
spectively.
The rate of leakage of '11In3+ from DPPC vesicles in the
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FIG. 3. Effect of serum on the structural integrity ofDPPC ves-
icles. (G22(c)) was monitored after addition of 1 volume of fresh
rabbit serum to DPPC vesicles in Pi/NaCl. The arrow indicates the
addition of Triton X-100 to a final concentration of 0.2%. The per-
centage of vesicles remaining intact was calculated by using Eq. 1 (see
text).
presence of serum was examined by PAC (Fig. 3). It appears
that rapid leakage of II'In3+ is confined to the early period of
the incubation. This suggests that there may be distinct popu-
lations of vesicles in our preparations. Addition of Triton X-100
to a final concentration of 0.2% led to rapid disruption of all the
DPPC vesicles and binding of the IllIn3+ by serum. Serum was
found to have a less marked effect on DPPC-cholesterol ves-
icles. Furthermore, the addition of 5% chloroform, in addition
to the 0.2% Triton, was necessary to completely disrupt
DPPC-cholesterol vesicles.
In Vivo Experiments. The greater stability of DPPC-cho-
lesterol vesicles in the presence of serum made them suitable
for in vivo measurements. The rate at which these vesicles,
injected intraperitoneally, underwent structural alterations
sufficient to cause leakage of lllIn3+ is shown in Fig. 4. The
curves represent different strains of mice and separate prepa-
rations of DPPC-cholesterol vesicles. However, both give
similar patterns for vesicle destruction, with 50% disruption
occuring in 10-13 hr. Based on counting rates, it was deter-
mined that the lllIn3+ was being excreted from the mice at
approximately 5% of the injected dose every 24 hr.
The PAC measurements give us an indication of the overall
integrity of the injected vesicles. Further information regarding
their fate was obtained from tissue radioactivity distribution
studies. The data in Fig. 5 indicate that the intraperitoneally
injected DPPC-cholesterol vesicles were rapidly removed from
the injection site via abdominal lymphatics with subsequent
drainage into the venous system and distribution throughout
the mouse by way of the circulation. The amount of l1lIn3+ in
the blood increased rapidly such that 50% of the recovered
111In3+ (42% of injected dose) was in the blood at 2.5 hr after
injection. Similar blood radioactivity levels have been observed
after intraperitoneal injection of other sonicated liposomes (14).
Coincident with the increase in lllIn3+ in the blood, a decrease
in the llIIn3+ recovered with the skin was observed. At 2.5 hr
only 16% of the recovered radioactivity (14% of the injected
dose) was found in the liver. At the later time points, (e.g., 29.5
hr), almost complete removal of lllIn3+ from the blood had
occurred and the liver had become the major site for lllIn3+
recovery. Less than 0.3% of the 111In3+ was detected in the brain
at any time point.
Comparison of PAC data (Fig. 4) with information at early
time points of the tissue distribution studies indicates that little
destruction of the DPPC-cholesterol vesicles occurred during
Biophysics: Hwang and Mauk
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FIG. 4. Loss of structural integrity of DPPC-cholesterol vesicles
in vivo after intraperitoneal injection into mice. The percentage of
vesicles remaining intact was calculated from (G22(0x)) by using Eq.
1 (see text). (A) Administration of 0.40 ml of DPPC-cholesterol
vesicles in Pi/NaCl containing 15 ACi of entrapped 111In3+ to a 16-g
C57BL/6 mouse. (B) Administration of 0.35 ml of DPPC-cholesterol
vesicles in Pi/NaCl containing 14 XCi of entrapped "'1In3+ to a 18.5-g
BALB/c mouse.
uptake of the liposomes from the site of injection. Two lines of
evidence suggest that the vesicles remain intact in the blood-
stream. The first is based on the nearly complete removal of
1 1In3+ from the blood within 24 hr. If vesicle destruction had
occurred in the circulation, the lllIn3+ would have bound to
serum proteins, mainly transferrin (13, 15), and consequently
be retained in the blood for extended periods of time. Fur-
thermore, the PAC measurements show that -80% of the ves-
icles remained intact 3 hr after vesicle administration.
The amount of radioactivity found in the liver increased
steadily during the first 17 hr, as expected, after administration
of small vesicles (16). This suggests that the DPPC-cholesterol
vesicles were cleared from the blood and taken up by the liver.
It is noteworthy that PAC measurements showed -35% of the
vesicles remaining intact 17 hr after injection (Fig. 4A) but only
6% of the radioactivity was in the blood at that time according
to tissue radioactivity distribution. This suggests that there were
intact vesicles lodged in body tissues. The contents of these
vesicles were slowly released as indicated by the further de-
crease in the percentage of intact vesicles remaining in the mice
(Fig. 4) and the constant radioactivity levels in various tissues
(Fig. 5).
Our results indicate that encapsulation in DPPC-cholesterol
vesicles affords considerable protection of the lllIn3+ from
interaction with tissues and biological fluids. This was further
substantiated by examining the fate of 111In3+ in 1 mM NTA/
Pi/NaCl injected intraperitoneally into mice. Immediately after
the injection, the (G22(o)) fell to 0.21 ± 0.02 and remained
steady over the next 2.5 hr. Tissue examinations on mice sac-
rificed 2.6 hr after intraperitoneal injection of NTA/"'1In3+
showed 0.2% of the 111In3+ in the blood and 0.4% in the skin.
More than 93% of the lllIn3+ was recovered with the intestine
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FIG. 5. Tissue distribution of '11In3+ after intraperitoneal in-
jection of DPPC-cholesterol vesicles containing entrapped lllln +.
The C57BL/6 mice used were 53 days old and had a mean weight of
17.3 g; blood volume was assumed to be 1.3 ml. X, Skin; 0, blood; 0,
liver; *, intestine; A, kidney; o, spleen; A, lung.
and was not removed by washing the tissue with 0.9% NaCl,
indicating binding of the 1"In3+ to tissue at or near the site of
injection. No significant excretion of lllIn3+ was detected in
the 24 hr after administration of NTA/"'1In3+ to other mice.
DISCUSSION
The versatility of liposomes as carriers of pharmacologically
active agents has become increasingly apparent. Entrapment
of therapeutic materials in various types of lipid vesicles can
in principle not only afford protection for the material but also
allow the rate and route of its uptake to be altered. Attempts
to determine the fate of administered liposomes by classical
radioactive tracer methods have been complicated by the dif-
ficulty in distinguishing entrapped radioactivity from that re-
leased from the liposomes. Alternative methods for studying
the fate of liposomes have been sought. McDougall et al. (17)
used electron paramagnetic resonance spectra to characterize
the integrity of unilamellar vesicles, containing the spin label
tempocholine, before injection and after their recovery in
mouse blood. More recently, Weinstein et al. (18) utilized the
self-quenching fluorescent properties of the entrapped dye
6-carboxyfluorescein to distinguish between material still re-
maining in vesicles and that released intracellularly in in vitro
cell suspension systems.
The approach developed in this paper for establishing the
structural integrity of vesicles by monitoring the molecular
motion of 1I1In3+ has broad applicability in vitro as well as in
vivo. In this method, lllIn3+ in the presence of a suitable che-
lator is added to the aqueous phase during liposome prepara-
tion. The ability to assess membrane integrity would not be
affected by the method used for formation of liposomes, the
nature of the membrane constituents, or the presence of other
entrapped components.
The in vitro experiments using entrapped llIn3+ clearly
show that the PAC technique is capable of detecting alterations
in membrane structure occurring upon the addition of serum
to vesicles. These findings are in agreement with a previous
report (19) indicating that some liposomes that are stable to
leakage of captured ions in physiological salt solutions become
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more leaky in the presence of fresh serum. The greater stability
of DPPC-cholesterol vesicles in the presence of serum was
anticipated based on previous reports that inclusion of choles-
terol in the bilayer results in a decrease in premeability of the
liposomes (20-22). This points out the usefulness of PAC for
rapid initial in vitro testing of liposomes of varying compositions
to assess their structural stability. This technique could screen
liposomes and eliminate from in vivo testing programs those
preparations that would undergo unsatisfactory rates of de-
struction upon entering the bloodstream.
More important, however, is the usefulness of the procedures
described in this paper for application to in vivo experiments.
We have shown that by using PAC it is possible to monitor
continuously the percentage of vesicles remaining intact in vivo.
This is a parameter not readily determinable by other tech-
niques. In addition, the PAC measurements suggest that vesicles
can remain intact in various tissues for extended periods and,
thereby, can slowly release the encapsulated material at those
sites. Our data do not allow determination of rates of vesicle
destruction in specific organs or tissues. However, the present
method can in principle be adapted to investigate the integrity
of vesicles in any specific area of the body by using lead
shielding to block out other areas. The data could also be
combined with tissue distributions obtained by using whole-
body scintillation scanners to yield more complete kinetic in-
formation. Alternatively, information on vesicle destruction
at specific sites can be obtained in future studies through in-jection of vesicle preparations containing sufficiently high levels
of entrapped lllIn3+ such that, upon sacrifice of the animals,
PAC measurements could be made on isolated organs and
tissues.
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